Manic-depressive illness and substance abuse

Psychiatric Annals

Volumn 27, Issue 7, 1997, Pages 507-511

  Swann, Alan C ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0031486074     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19970701-12     Document Type: Review

References (57)

1. Kessler RC, McGonagle KA, Zhao S, et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Arch Gen Psychiatry. 1994; 51:8-19.
2. Regier DA, Farm ME, Rae DS, et al. Comorbidity of mental disorders with alcohol and other drug abuse: results from the Epidemiologic Catchment Area (ECA) study. JAMA. 1990; 264:2511-2518.
3. Brady KT, Lydiard RB. Bipolar affective disorder and substance abuse. J Clin Psychopharmacol. 1992; 12:178-22S.
4. Helzer JE, Pryzbeck TR. The co-occurrence of alcoholism with other psychiatric disorders in the general population and its impact on treatment. J Stud Alcohol. 1988; 49:219-224.
5. Borchardt CM, Bernstein GA. Comorbid disorders in hospitalized bipolar adolescents compared with unipolar depressed adolescents. Child Psychiatry Hum Dev. 1995; 26:11-18.
6. Stephens JH, McHugh PR. Characteristics and long-term follow-up of patients hospitalized for mood disorders in the Phipps Clinic, 1913-1940. J Nerv Ment Dis. 1991; 179:64-73.
7. Miller FT, Busch F, Tanenbaum JH. Drug abuse in schizophrenia and bipolar disorder. Am J Drug Alcohol Abuse. 1989; 15:291-295.
8. Akiskal HS, Maser JD, Zeller PJ, et al. Switching from 'unipolar' to bipolar II. An 11-year prospective study of clinical and temperamental predictors in 559 patients. Arch Gen Psychiatry. 1994; 52:114-123.
9. Taylor MA. Manic-depressive illness and acute schizophrenia: a clinical, family history, and treatment-response study. Am J Psychiatry. 1974; 131:678-682.
10. Anthony JC, Petronis KR. Epidemiologic evidence on suspected associations between cocaine use and psychiatric disturbances. NIDA Res Monogr. 1991; 110:71-94.
11. Rounsaville BJ, Anton SF, Carroll K, Budde D, Prusoff BA, Gawin F. Psychiatric diagnoses of treatment-seeking cocaine abusers. Arch Gen Psychiatry. 1991; 48:43-51.
12. Strakowski SM, McElroy SL, Keck PE, West SA. The co-occurrence of mania with medical and other psychiatric disorders. Int J Psychiatry Med. 1994; 24:303-328.
13. Neighbors B, Kempton T, Forehand R. Co-occurrence of substance abuse with conduct, anxiety, and depression disorders in juvenile delinquents. Addict Behav. 1992; 17:379-386.
14. Lemere F, Smith JW. Hypomanic personality trait in cocaine addiction. Br J Addict. 1990; 85:575-576.
15. Weiss RD, Mirin SM. Subtypes of cocaine abusers. Psychiatr Clin North Am. 1986; 9:491-501.
16. Leith NJ, Barrett RJ. Effects of chronic amphetamine or reserpine on self-stimulation: animal model of depression. Psychopharmacology. 1980; 72:9-15.
17. Kokkinidis L, McCarter BD. Postcocaine depression and sensitization of brain-stimulation reward: analysis of reinforcement and performance effects. Pharmacol Biochem Behav. 1990; 36:463-471.
18. Koob GF, Weiss F. Neuropharmacology of cocaine and ethanol dependence. Recent Dev Alcohol. 1992; 10:201-233.
19. Nagel K, Adler LE, Bell J, Nagamoto HT, Freedman R. Lithium carbonate and mood disorder in recently detoxified alcoholics: a double-blind, placebo-controlled pilot study. Alcoholism: Clin Exp Res. 1991; 15:978-981.
20. Satel SL, Edell WS. Cocaine-induced paranoia and psychosis proneness. Am J Psychiatry. 1991; 148:1708-1711.
21. Imade AG, Ebie JC. A retrospective study of symptom patterns of cannabis-induced psychosis. Acta Psychiatr Scand. 1991; 83:134-136.
22. Blum K, Cull JG, Braverman ER, Comings DE. Reward deficiency syndrome. American Scientist. 1996; 84:132-145.
23. Marvel GA, Hartmann BR. An 'economic' theory of addiction, hypomania, and sensation seeking. Int J Addict. 1986; 21:495-508.
24. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev. 1986; 4:167-226.
25. Reich LH, Davis RK, Himmelhoch JM. Excessive alcohol use in manic-depressive illness. Am J Psychiatry. 1974; 131:83-86.
26. Sanguineti VR, Samuel SE. Comorbid substance abuse and recovery from acute psychiatric relapse. Hosp Community Psychiatry. 1993; 44:1073-1076.
27. Mueser KT, Yarnold PR, Bellack AS. Diagnostic and demographic correlates of substance abuse in schizophrenia and major affective disorder. Acta Psychiatr Scand. 1992; 85:48-55.
28. Winokur G, Coryell W, Akiskal HS, et al. Alcoholism in manic-depressive (bipolar) illness: familial illness, course of illness, and the primary-secondary distinction. Am J Psychiatry. 1995; 152:365-372.
29. Winokur G, Coryell W, Akiskal HS, Endicott J, Keller M, Mueller T. Manic-depressive (bipolar) disorder: the course in light of a prospective ten-year follow-up of 131 patients. Acta Psychiatr Scand. 1994; 89:102-110.
30. Post RM, Rubinow DR, Ballenger JC. Conditioning and sensitization in the longitudinal course of affective illness. Br J Psychiatry. 1986; 149:191-201.
31. Weiss SRB, Post RM, Costello M, Nutt DJ, Tandiarz S. Carbamazepine retards the development of cocaine-kindled seizures but not sensitization to cocaine-induced hyperactivity. Neuropsychopharmacology. 1990; 3:273-281.
32. Akiskal HS, Downs J, Jordan P, Watson S, Daugherty D, Pruitt DB. Affective disorders in referred children and younger siblings of manic-depressives. Mode of onset and prospective course. Arch Gen Psychiatry: 1985; 42:996-1003.
33. Ingraham LJ, Wender PH. Risk for affective disorder and alcohol and other drug abuse in the relatives of affectively ill adoptees. J Affect Disord. 1992; 26:45-51.
34. Sokolski KN, Cummings JL, Abrams BI, Demet EM, Katz LS, Costa JF. Effects of substance abuse on hallucination rates and treatment responses in chronic psychiatric patients. J Clin Psychiatry. 1994; 55:380-387.
35. Sonne SC, Brady KT, Morton WA. Substance abuse and bipolar affective disorder. J Nerv Ment Dis. 1994; 182:349-354.
36. Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JLJ, Davis JM, Lewis DA. Predicting the 'revolving door' phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am J Psychiatry. 1995; 152:856-861.
37. Warner R, Taylor D, Wright J, et al. Substance use among the mentally ill: prevalence, reasons for use, and effects on illness. Am J Orthopsychiatry. 1994; 64:30-39.
38. Burke KC, Burke JD, Regier DA, Rae DS. Age at onset of selected mental disorders in five community populations. Arch Gen Psychiatry. 1990; 47:511-518.
39. Bukstein OG, Glancy LJ, Kaminer Y. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J Am Acad Child Adolesc Psychiatry. 1992; 31:1041-1045.
40. Strakowski SM, Keck PE, McElroy SL, Lonczak HS, West SA. Chronology of comorbid and principal syndromes in first-episode psychosis. Compr Psychiatry. 1995; 36:106-112.
41. Merikangas KR, Prusoff BA, Weissman MM. Parental concordance for affective disorders: psychopathology in offspring. J Affect Disord. 1988; 15:279-290.
42. Burke JD, Burke KC, Rae DS. Increased rates of drug abuse and dependence after onset of mood or anxiety disorders in adolescence. Hosp Community Psychiatry. 1994; 45:451-455.
43. O'Sullivan K, Rynne C, Miller J, et al. A follow-up study on alcoholics with and without co-existing affective disorder. Br J Psychiatry. 1988; 152:813-819.
44. Himmelhoch JM, Mulla D, Neil JF, Detre TP, Kupfer DJ. Incidence and severity of mixed affective states in a bipolar population. Arch Gen Psychiatry. 1976; 33:1062.
45. Himmelhoch JM, Garfinkel ME. Sources of lithium resistance in mixed mania. Psychopharmacol Bull. 1986; 22:613-620.
46. Black DW, Winokur G, Bell S, Nasrallah A, Hulbert J. Complicated mania. Comorbidity and immediate outcome in the treatment of mania. Arch Gen Psychiatry. 1988; 45:232-236.
47. Sandkuyl LA, Ott J. Affective disorders: evaluation of a three-allele model accounting for clinical heterogeneity. Genet Epidemiol. 1989; 6:265-269.
48. Brady KT, Sonne SC, Anton R. Valproate in the treatment of acute bipolar affective episodes complicated by substance abuse: a pilot study. J Clin Psychiatry. 1995; 56:118-121.
49. Goldman DL, Post RM. The puzzle of noncompliance in the manic patient. Bull Menninger Clin. 1991; 55:248-253.
50. Marttunen MJ, Aro HM, Henriksson MM, Lonnqvist JK. Mental disorders in adolescent suicide. DSM-III-R axes in suicides among 13- to 19-year-olds in Finland. Arch Gen Psychiatry. 1991; 48:834-839.
51. Bulik CM, Carpenter LL, Kupfer DJ, Frank E. Features associated with suicide attempts in recurrent major depression. J Affect Disord. 1990; 18:29-37.
52. Brent DA, Perper JA, Moritz G, Baugher M, Schweers J, Roth C. Suicide in affectively ill adolescents: a case-control study. J Affect Disord. 1994; 31:193-202.
53. Bukstein OG, Brent DA, Perper JA, et al. Risk factors for completed suicide among adolescents with a lifetime history of substance abuse: a case-control study. Acta Psychiatr Scand. 1993; 88:403-408.
54. Vestergaard P, Aagaard J. Five-year mortality in lithium-treated manic-depressive patients. J Affect Disord. 1991; 21:33-38.
55. Beninger RJ, Herz RS. Pimozide blocks the establishment but not the expression of cocaine-produced environment-specific conditioning. Life Sci. 1986; 38:1425-1431.
56. Kalivas PW, Sorg BA, Hooks MS. The pharmacology and neural circuitry of sensitization to psychostimulants. Behavioural Pharmacology. 1993; 4:315-334.
57. Milling RN, Faulkner LR, Craig JM. Problems in the recognition and treatment of patients with dual diagnoses. J Subst Abuse Treat. 1994; 11:267-271.